Bullish & Foolish
Full VERU fundamentals All 466 on the Survival Watch

VERUVERU INC.

Is Veru struggling financially?

Yes, by its own account. Veru told the SEC on 13 May 2026, in Form 10-Q, that there is substantial doubt about its ability to continue as a going concern.

Going concern disclosed May 2026

30/100

Fragile

Cries for help

  • Share sales and shelf filings

    All of the securities in the offering were sold by the Company. The offering was made pursuant to the Company’s shelf registration statement on Form S- 3 (File No. 333 - 270606 ) in effect at that time.

    Form 10-Q, filed 13 May 2026. Read it on SEC.gov

  • Reverse stock split

    On August 8, 2025, the Company effected a 1 -for- 10 reverse stock split of its issued and outstanding common stock. As a result of the reverse split, each 10 shares of issued and outstanding common stock were automatically converted into one share of common stock.

    Form 10-Q, filed 13 May 2026. Read it on SEC.gov

Signs of a way out

Nothing in the filings we have read names a way out.

Sector
Biotech/Pharma
Market cap
$45.0M
Source filing
10-Q 13 May 2026
Balance sheet
30 Jun 2026

Cash runway

  • 8months

    If the burn speeds up

    Empty by Mar 2027

  • 11months

    If it eases off

    Empty by May 2027

Both rows are the same reported burn flexed 15% either way, and neither assumes the company raises a cent.

Out of cashTwo years or more

The runway math

Cash and short-term investments

$23.9M

÷

Cash burned over the last 12 months

$30.0M

What Veru told the SEC

…Additional capital may not be available at such times and in such amounts as needed by us to fund our activities on a timely basis. These uncertainties raise substantial doubt regarding our ability to continue as a going concern for a period of twelve months subsequent to the issuance date of these financial statements. Certain elements of our operating plan to alleviate the conditions that raise substantial…

VERU INC., Form 10-Q, filed 13 May 2026.

Read the filing on SEC.gov

What this means

  • Not a bankruptcy filing, and not a prediction.
  • It is the company’s own statement, agreed with its auditor, that the doubt is material enough to disclose.
  • The runway is arithmetic on two reported numbers, not a forecast. Companies carry this language for years, raise money and keep going.

What else the numbers show

  • 51.1% share-count increase The company issued stock. Each share now owns 33.8% less of the business than a year ago, before any change in the price.
  • Cash burn is narrowing It is spending 49% less cash per year than it was, so the runway above is lengthening rather than shortening.

Other Biotech/Pharma companies that filed the doubt